Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Weekend Drug Holiday of Dasatinib in CML Patients Not Tolerating Standard Dosing Regimens. Reducing Toxicity with Maintained Disease Control.

Paul La Rosee, MD, Armin Leitner, MD, Philippe Martiat, MD, Thomas Klag, MD, Samina Shazi, MD, Anne Treschl, MD, Martin C Müller, MD, Thomas Schenk, MD, Benjamin Hanfstein, Andreas Hochhaus, MD

Blood (2009) 114 (22): 1119.

https://doi.org/10.1182/blood.V114.22.1119.1119

Published: 2009

Journal Articles

Prevalence, determinants, and outcomes of nonadherence to imatinib therapy in patients with chronic myeloid leukemia: the ADAGIO study

Lucien Noens, Marie-Anne van Lierde, Robrecht De Bock, Gregor Verhoef, Pierre Zachée, Zwi Berneman, Philippe Martiat, Philippe Mineur, Koen Van Eygen, Karen MacDonald, Sabina De Geest, Tara Albrecht, Ivo Abraham

Blood (2009) 113 (22): 5401–5411.

https://doi.org/10.1182/blood-2008-12-196543

Published: 2009

Journal Articles

microRNA-29c and microRNA-223 down-regulation has in vivo significance in chronic lymphocytic leukemia and improves disease risk stratification

Basile Stamatopoulos, Nathalie Meuleman, Benjamin Haibe-Kains, Pascale Saussoy, Eric Van Den Neste, Lucienne Michaux, Pierre Heimann, Philippe Martiat, Dominique Bron, Laurence Lagneaux

Blood (2009) 113 (21): 5237–5245.

https://doi.org/10.1182/blood-2008-11-189407

Published: 2009

Includes: Supplemental data

Journal Articles

MicroRNA-29c and 223 Are Powerful Prognostic Factors for Chronic Lymphocytic Leukemia and Improve Risk Stratification When Combined with ZAP70 and LPL in a qPCR Score.

Basile Stamatopoulos, Nathalie Meuleman, Dominique Bron, Benjamin Haibe-Kains, Pascale Saussoy, Philippe Martiat, Laurence Lagneaux

Blood (2008) 112 (11): 1066.

https://doi.org/10.1182/blood.V112.11.1066.1066

Published: 2008

Journal Articles

Identification of a Human Natural Regulatory T Cell Micro-RNA Signature and Demonstration of the Major Role Played by miR31 in the Control of Foxp3 Expression

Redouane Rouas, Hussein Fayyad Kazan, Nabil El Zein, Philippe Lewalle, Françoise Rothé, Haidar Akl, Arsène Burny, Pedro Romero, Philippe Martiat, Bassam Badran

Blood (2008) 112 (11): 1526.

https://doi.org/10.1182/blood.V112.11.1526.1526

Published: 2008

Journal Articles

Patient Nonadherence and Treatment Response to Imatinib in Patients with Chronic Myeloid Leukemia: Results from the ADAGIO Study

Lucien Noens, Marie-Anne van Lierde, Robrecht De Bock, Gregor Verhoef, Pierre Zachee, Zwi Berneman, Philippe Martiat, Philippe Mineur, Koen Van Eygen, Karen MacDonald, Sabina De Geest, Tara Albrecht, Laurie Letvak, Ivo Abraham

Blood (2008) 112 (11): 2379.

https://doi.org/10.1182/blood.V112.11.2379.2379

Published: 2008

Journal Articles

Dendritic Cells, Generated and Matured, after Elutriation, in Clinical Grade Bags, Differ in Immune Functions When Compared to Classical DCs Generated in Plates.

Redouane Rouas, Haidar Akl, Bassam Badran, Larissa Di Pietrantonio, Hugues Duvillier, Philippe Martiat, Philippe Lewalle

Blood (2008) 112 (11): 1544.

https://doi.org/10.1182/blood.V112.11.1544.1544

Published: 2008

Journal Articles

Valproic Acid Induces Apoptosis in Chronic Lymphocytic Leukemia Cells by Targeting Several Pro- and Anti-Apoptotic Genes.

Basile Stamatopoulos, PhD, Nathalie Meuleman, Alain Kentos, Philippe Hermans, Philippe Martiat, Dominique Bron, Laurence Lagneaux

Blood (2007) 110 (11): 3131.

https://doi.org/10.1182/blood.V110.11.3131.3131

Published: 2007

Journal Articles

Reduced Intensity Conditioning Hematopoietic Stem Cell Transplantation (HSCT) with Mesenchymal Stem Cells (MSC) Infusion for Treatment of Metachromatic Leukodystrophy (MLD): A Case Report.

Nathalie Meuleman, MD, C. Rocha, MD, Jalil Bennani, MD, Tatiana Tondreau, PhD, Alain Delforge, MD, Philippe Lewalle, MD, Philippe Martiat, PhD, Laurence Lagneaux, PhD, Dominique Bron, PhD

Blood (2006) 108 (11): 5255.

https://doi.org/10.1182/blood.V108.11.5255.5255

Published: 2006

Journal Articles

Infusion of Mesnchymal Stem Cells (MSC) in Patients with Poor Hematopoietic Recovery after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT): A Pilot Study.

Nathalie Meuleman, MD, Imran Ahmad, MD, Tatiana Tondreau, PHD, Alain Delforge, PHD, Philippe Martiat, PHD, Laurence Lagneaux, PHD, Dominique Bron, PHD

Blood (2006) 108 (11): 2958.

https://doi.org/10.1182/blood.V108.11.2958.2958

Published: 2006

Journal Articles

The Role of GM-CSF in Haplo-Identical Transplant Patients Who Do Not Benefit from NK Alloreactivity.

Philippe Lewalle, MD, Alain Delforge, PhD, Berengere Nowak, BSc, Virginie Misplon, BSc, Jalil Bennani, MD, PhD, Dominique Bron, MD, PhD, Philippe Martiat, MD, PhD

Blood (2005) 106 (11): 2912.

https://doi.org/10.1182/blood.V106.11.2912.2912

Published: 2005

Journal Articles

Can Addition of GM-CSF in Adult Haplo-Identical Transplant Who Cannot Benefit from NK Alloreactivity Improve the Relapse Rate of Advanced Leukemia: A 3 Step Study.

Philippe Lewalle, MD, Alain Delforge, PhD, Berengere Nowak, BS, Virginie Misplon, Laurence Lagneaux, PhD, Koen Theunissen, MD, PhD, Jalil Bennani, MD, Dominique Bron, MD, PhD, Philippe Martiat, MD, PhD

Blood (2004) 104 (11): 4975.

https://doi.org/10.1182/blood.V104.11.4975.4975

Published: 2004

Journal Articles

Immunological Recovery after Nonmyeloablative Transplant: A Prospective Study of 24 Patients Treated in a Single Center.

Dominique Bron, MD PhD, Van Hyunh, MD, Virginie Dewilde, MD, Jalil Bennani, MD, Philippe Lewalle, MD, Phuong Huynh, MD, Rita Leroy, Patrick Crombez, Louisette Debusscher, MD, Walter Feremans, MD, PhD, Michel Bernier, MD, Philippe Martiat, MD

Blood (2004) 104 (11): 5044.

https://doi.org/10.1182/blood.V104.11.5044.5044

Published: 2004

Journal Articles

Fludarabine Phosphate-Based Nonmyeloablative Stem Cell Transplantation in the Elderly Patients: A BHS Study.

Dominique Bron, MD, PhD, Pierre Zachée, MD, Johan Maertens, MD, Koen Theunissen, MD, Augustin Ferrant, MD, PhD, Philippe Martiat, MD, PhD, Chantal Doyen, MD, Luc Noens, MD, Wilfried Schroyens, MD, Dominique Sellesslag, MD, Hilde Demuynck, MD, Rick Schots, MD, PhD, Anne De Meuter, Marc Boogaerts, MD, PhD

Blood (2004) 104 (11): 5046.

https://doi.org/10.1182/blood.V104.11.5046.5046

Published: 2004

NARROW

Weekend Drug Holiday of Dasatinib in CML Patients Not Tolerating Standard Dosing Regimens. Reducing Toxicity with Maintained Disease Control.

Prevalence, determinants, and outcomes of nonadherence to imatinib therapy in patients with chronic myeloid leukemia: the ADAGIO study

microRNA-29c and microRNA-223 down-regulation has in vivo significance in chronic lymphocytic leukemia and improves disease risk stratification

MicroRNA-29c and 223 Are Powerful Prognostic Factors for Chronic Lymphocytic Leukemia and Improve Risk Stratification When Combined with ZAP70 and LPL in a qPCR Score.

Identification of a Human Natural Regulatory T Cell Micro-RNA Signature and Demonstration of the Major Role Played by miR31 in the Control of Foxp3 Expression

Patient Nonadherence and Treatment Response to Imatinib in Patients with Chronic Myeloid Leukemia: Results from the ADAGIO Study

Dendritic Cells, Generated and Matured, after Elutriation, in Clinical Grade Bags, Differ in Immune Functions When Compared to Classical DCs Generated in Plates.

Valproic Acid Induces Apoptosis in Chronic Lymphocytic Leukemia Cells by Targeting Several Pro- and Anti-Apoptotic Genes.

Reduced Intensity Conditioning Hematopoietic Stem Cell Transplantation (HSCT) with Mesenchymal Stem Cells (MSC) Infusion for Treatment of Metachromatic Leukodystrophy (MLD): A Case Report.

Infusion of Mesnchymal Stem Cells (MSC) in Patients with Poor Hematopoietic Recovery after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT): A Pilot Study.

The Role of GM-CSF in Haplo-Identical Transplant Patients Who Do Not Benefit from NK Alloreactivity.

Can Addition of GM-CSF in Adult Haplo-Identical Transplant Who Cannot Benefit from NK Alloreactivity Improve the Relapse Rate of Advanced Leukemia: A 3 Step Study.

Immunological Recovery after Nonmyeloablative Transplant: A Prospective Study of 24 Patients Treated in a Single Center.

Fludarabine Phosphate-Based Nonmyeloablative Stem Cell Transplantation in the Elderly Patients: A BHS Study.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only